Sarepta Therapeutics, Inc. SRPT Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s investment proceeds?
- Sarepta Therapeutics, Inc. (SRPT) reported investment proceeds of $38.89M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Sarepta Therapeutics, Inc.'s investment proceeds decreased by 4.6% year-over-year, from $40.76M to $38.89M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s investment proceeds?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s investment proceeds has grown at a -21.8% compound annual growth rate (CAGR), from $466M to $174.1M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.